DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,272 | -43.8% | 335,885 | -37.8% | 0.04% | -33.9% |
| Q2 2023 | $7,608 | +13.3% | 540,316 | +24.3% | 0.06% | +10.7% |
| Q1 2023 | $6,716 | -29.3% | 434,670 | -25.0% | 0.06% | -59.4% |
| Q4 2022 | $9,501 | -99.8% | 579,654 | +87.6% | 0.14% | +84.0% |
| Q3 2022 | $5,716,000 | +20.7% | 308,969 | -14.2% | 0.08% | +29.3% |
| Q2 2022 | $4,734,000 | +84.3% | 360,015 | +29.9% | 0.06% | +81.2% |
| Q1 2022 | $2,569,000 | +230.6% | 277,155 | +1936.7% | 0.03% | +300.0% |
| Q4 2020 | $777,000 | – | 13,608 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |